News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
21 Results
21 Results
Routine lab tests are not a reliable way to diagnose Long COVID
Findings from this RECOVER study will inform future efforts to develop tools for diagnosing Long COVID.
News Release
Leadership Q&A: NIH to bolster RECOVER Long COVID research efforts
Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.
Q&A
NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million
This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.
News Release
Changes in the body provide clues for the development of Long COVID
A research team that includes RECOVER researchers found changes in the immune systems of people with Long COVID.News Release
RECOVER Research Awards
RECOVER has awarded over $37 million in funding to more than 40 pathobiology studies that will further our understanding of how COVID affects different body tissues and organs.
News Release